Back to matrix
GH-axis
Ipamorelin
None of the 30 tracked EU+ jurisdictions lists Ipamorelin as authorised. This page summarises approval status, brands, shortages and recent regulatory changes by country.
Related regulatory compounds
Country-by-country approval and availability
30 EU+ jurisdictions covered.
Research only